共 47 条
- [1] Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) : 88 - 94Advani, Ranjana H.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Med Ctr, Stanford, CA 94305 USA Stanford Univ, Med Ctr, Stanford, CA 94305 USABuggy, Joseph J.论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics, Sunnyvale, CA USA Stanford Univ, Med Ctr, Stanford, CA 94305 USASharman, Jeff P.论文数: 0 引用数: 0 h-index: 0机构: Willamette Valley Canc Ctr, US Oncol, Springfield, OR USA Stanford Univ, Med Ctr, Stanford, CA 94305 USASmith, Sonali M.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Chicago, IL 60637 USA Stanford Univ, Med Ctr, Stanford, CA 94305 USABoyd, Thomas E.论文数: 0 引用数: 0 h-index: 0机构: Yakima Valley Mem Hosp, US Oncol, Yakima, Japan Stanford Univ, Med Ctr, Stanford, CA 94305 USAGrant, Barbara论文数: 0 引用数: 0 h-index: 0机构: Univ Vermont, Burlington, VT USA Stanford Univ, Med Ctr, Stanford, CA 94305 USAKolibaba, Kathryn S.论文数: 0 引用数: 0 h-index: 0机构: NW Canc Specialists, US Oncol, Vancouver, WA USA Stanford Univ, Med Ctr, Stanford, CA 94305 USAFurman, Richard R.论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Coll, New York, NY USA Stanford Univ, Med Ctr, Stanford, CA 94305 USARodriguez, Sara论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics, Sunnyvale, CA USA Stanford Univ, Med Ctr, Stanford, CA 94305 USAChang, Betty Y.论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics, Sunnyvale, CA USA Stanford Univ, Med Ctr, Stanford, CA 94305 USASukbuntherng, Juthamas论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics, Sunnyvale, CA USA Stanford Univ, Med Ctr, Stanford, CA 94305 USAIzumi, Raquel论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics, Sunnyvale, CA USA Stanford Univ, Med Ctr, Stanford, CA 94305 USAHamdy, Ahmed论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics, Sunnyvale, CA USA Stanford Univ, Med Ctr, Stanford, CA 94305 USAHedrick, Eric论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics, Sunnyvale, CA USA Stanford Univ, Med Ctr, Stanford, CA 94305 USAFowler, Nathan H.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Stanford Univ, Med Ctr, Stanford, CA 94305 USA
- [2] [Anonymous], 2020, IMBR IBR
- [3] Splenic marginal zone lymphoma: from genetics to management[J]. BLOOD, 2016, 127 (17) : 2072 - 2081Arcaini, Luca论文数: 0 引用数: 0 h-index: 0机构: Univ Pavia, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy Fdn Ist Ricovero & Cura Carattere Sci Policlin Sa, Dept Hematol Oncol, Pavia, Italy Univ Pavia, Dept Mol Med, Via Palestro 3, I-27100 Pavia, ItalyRossi, Davide论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Southern Switzerland, Div Hematol, Bellinzona, Switzerland Oncol Res Inst, Bellinzona, Switzerland Univ Pavia, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy论文数: 引用数: h-index:机构:
- [4] Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma[J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (12) : 2761 - 2774Bernard, Sophie论文数: 0 引用数: 0 h-index: 0机构: INSERM, U978, Bobigny, France Univ Paris 13, Sorbonne Paris Cite, Labex Inflamex, Bobigny, France Hop Avicenne, AP HP, Serv Hematol Biol, F-93009 Bobigny, France INSERM, U978, Bobigny, FranceDanglade, Damien论文数: 0 引用数: 0 h-index: 0机构: Hop Avicenne, AP HP, Serv Hematol Biol, F-93009 Bobigny, France INSERM, U978, Bobigny, FranceGardano, Laura论文数: 0 引用数: 0 h-index: 0机构: INSERM, U978, Bobigny, France Univ Paris 13, Sorbonne Paris Cite, Labex Inflamex, Bobigny, France INSERM, U978, Bobigny, FranceLaguillier, Christelle论文数: 0 引用数: 0 h-index: 0机构: Hop Jean Verdier, AP HP, Serv Biochim, Bondy, France INSERM, U978, Bobigny, FranceLazarian, Gregory论文数: 0 引用数: 0 h-index: 0机构: Hop Avicenne, AP HP, Serv Hematol Biol, F-93009 Bobigny, France INSERM, U978, Bobigny, FranceRoger, Claudine论文数: 0 引用数: 0 h-index: 0机构: Hop Avicenne, AP HP, Serv Hematol Biol, F-93009 Bobigny, France INSERM, U978, Bobigny, FranceThieblemont, Catherine论文数: 0 引用数: 0 h-index: 0机构: Hop St Louis, AP HP, Hematol, Paris, France INSERM, U978, Bobigny, FranceMarzec, Jacek论文数: 0 引用数: 0 h-index: 0机构: Univ London, Barts Canc Inst, London, England INSERM, U978, Bobigny, France论文数: 引用数: h-index:机构:Cymbalista, Florence论文数: 0 引用数: 0 h-index: 0机构: INSERM, U978, Bobigny, France Univ Paris 13, Sorbonne Paris Cite, Labex Inflamex, Bobigny, France Hop Avicenne, AP HP, Serv Hematol Biol, F-93009 Bobigny, France INSERM, U978, Bobigny, France论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:
- [5] Bertoni Francesco, 2018, F1000Res, V7, P406, DOI 10.12688/f1000research.13826.1
- [6] Therapy-Related Myelodysplasia and Acute Myeloid Leukemia[J]. SEMINARS IN ONCOLOGY, 2013, 40 (06) : 666 - 675Bhatia, Smita论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Populat Sci, Duarte, CA USA City Hope Comprehens Canc Ctr, Dept Populat Sci, Duarte, CA USA
- [7] Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials[J]. HAEMATOLOGICA, 2017, 102 (10) : 1796 - 1805Brown, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Dana Farber Canc Inst, Boston, MA 02115 USAMoslehi, Javid论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ Sch Med, Div Cardiovasc Med, Nashville, TN USA Vanderbilt Univ Sch Med, Cardiooncol Program, Nashville, TN USA Dana Farber Canc Inst, Boston, MA 02115 USAO'Brien, Susan论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA Dana Farber Canc Inst, Boston, MA 02115 USAGhia, Paolo论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, Milan, Italy IRCCS Ist Sci San Raffaele, Milan, Italy Dana Farber Canc Inst, Boston, MA 02115 USAHillmen, Peter论文数: 0 引用数: 0 h-index: 0机构: CA Leeds Teaching Hosp, St James Inst Oncol, Leeds, W Yorkshire, England Dana Farber Canc Inst, Boston, MA 02115 USACymbalista, Florence论文数: 0 引用数: 0 h-index: 0机构: Hop Avicenne, AP HP, UMR Paris13, INSERM,U978, Bobigny, France Dana Farber Canc Inst, Boston, MA 02115 USAShanafelt, Tait D.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA Dana Farber Canc Inst, Boston, MA 02115 USAFraser, Graeme论文数: 0 引用数: 0 h-index: 0机构: McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada Dana Farber Canc Inst, Boston, MA 02115 USARule, Simon论文数: 0 引用数: 0 h-index: 0机构: Plymouth Univ, Sch Med, Dept Haematol, Plymouth, Devon, England Dana Farber Canc Inst, Boston, MA 02115 USAKipps, Thomas J.论文数: 0 引用数: 0 h-index: 0机构: Moores UCSD Canc Ctr, San Diego, CA USA Dana Farber Canc Inst, Boston, MA 02115 USACoutre, Steven论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Stanford, CA 94305 USA Stanford Canc Inst, Stanford, CA USA Dana Farber Canc Inst, Boston, MA 02115 USADilhuydy, Marie-Sarah论文数: 0 引用数: 0 h-index: 0机构: Hop Haut Leveque, Pessac, France Dana Farber Canc Inst, Boston, MA 02115 USA论文数: 引用数: h-index:机构:Tedeschi, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Niguarda Ca Granda, Milan, Italy Dana Farber Canc Inst, Boston, MA 02115 USAJaeger, Ulrich论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Vienna, Austria Dana Farber Canc Inst, Boston, MA 02115 USADreyling, Martin论文数: 0 引用数: 0 h-index: 0机构: Klinikum Ludwig Maximilians Univ Munchen, Dept Med 3, Campus Grosshadern, Munich, Germany Dana Farber Canc Inst, Boston, MA 02115 USAByrd, John C.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA Dana Farber Canc Inst, Boston, MA 02115 USAHowes, Angela论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, High Wycombe, Bucks, England Dana Farber Canc Inst, Boston, MA 02115 USATodd, Michael论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Dana Farber Canc Inst, Boston, MA 02115 USAVermeulen, Jessica论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Leiden, Netherlands Dana Farber Canc Inst, Boston, MA 02115 USAJames, Danelle F.论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics, Sunnyvale, CA USA Dana Farber Canc Inst, Boston, MA 02115 USAClow, Fong论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics, Sunnyvale, CA USA Dana Farber Canc Inst, Boston, MA 02115 USAStyles, Lori论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics, Sunnyvale, CA USA Dana Farber Canc Inst, Boston, MA 02115 USAValentino, Rudy论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics, Sunnyvale, CA USA Dana Farber Canc Inst, Boston, MA 02115 USAWildgust, Mark论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Dana Farber Canc Inst, Boston, MA 02115 USAMahler, Michelle论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Dana Farber Canc Inst, Boston, MA 02115 USABurger, Jan A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia Dept, Houston, TX 77030 USA Dana Farber Canc Inst, Boston, MA 02115 USA
- [8] A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (06) : 741 - 748Brown, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAFriedberg, Jonathan W.论文数: 0 引用数: 0 h-index: 0机构: Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAFeng, Yang论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAScofield, Sarah论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAPhillips, Kimberly论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USADal Cin, Paola论文数: 0 引用数: 0 h-index: 0机构: Brigham & Womens Hosp, Boston, MA 02115 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAJoyce, Robin论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USATakvorian, Ronald W.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAFisher, David C.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAFisher, Richard I.论文数: 0 引用数: 0 h-index: 0机构: Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USALiesveld, Jane论文数: 0 引用数: 0 h-index: 0机构: Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAMarquis, Diana论文数: 0 引用数: 0 h-index: 0机构: Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USANeuberg, Donna论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USAFreedman, Arnold S.论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
- [9] Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study[J]. LEUKEMIA, 2020, 34 (03) : 787 - 798Burger, Jan A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USABarr, Paul M.论文数: 0 引用数: 0 h-index: 0机构: Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USARobak, Tadeusz论文数: 0 引用数: 0 h-index: 0机构: Med Univ Lodz, Copernicus Mem Hosp, Lodz, Poland Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAOwen, Carolyn论文数: 0 引用数: 0 h-index: 0机构: Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAGhia, Paolo论文数: 0 引用数: 0 h-index: 0机构: Univ Vita Salute San Raffaele, Milan, Italy IRCCS Osped San Raffaele, Milan, Italy Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USATedeschi, Alessandra论文数: 0 引用数: 0 h-index: 0机构: ASST Grande Osped Metropolitano Niguarda, Milan, Italy Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USABairey, Osnat论文数: 0 引用数: 0 h-index: 0机构: Rabin Med Ctr, Petah Tiqwa, Israel Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAHillmen, Peter论文数: 0 引用数: 0 h-index: 0机构: Univ Leeds, Leeds Teaching Hosp, St James Inst Oncol, Leeds, W Yorkshire, England Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USACoutre, Steven E.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Stanford Canc Ctr, Stanford, CA 94305 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USADevereux, Stephen论文数: 0 引用数: 0 h-index: 0机构: NHS Fdn Trust, Kings Coll Hosp, London, England Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAGrosicki, Sebastian论文数: 0 引用数: 0 h-index: 0机构: Silesiam Med Univ, Dept Hematol & Canc Prevent, Katowice, Poland Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAMcCarthy, Helen论文数: 0 引用数: 0 h-index: 0机构: Royal Bournemouth Gen Hosp, Bournemouth, Dorset, England Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USASimpson, David论文数: 0 引用数: 0 h-index: 0机构: North Shore Hosp, Auckland, New Zealand Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAOffner, Fritz论文数: 0 引用数: 0 h-index: 0机构: Univ Ziekenhuis Gent, Ghent, Belgium Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAMoreno, Carol论文数: 0 引用数: 0 h-index: 0机构: Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, Barcelona, Spain Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USADai, Sandra论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics LLC, Sunnyvale, CA USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USALal, Indu论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics LLC, Sunnyvale, CA USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USADean, James P.论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics LLC, Sunnyvale, CA USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USAKipps, Thomas J.论文数: 0 引用数: 0 h-index: 0机构: UCSD Moores Canc Ctr, San Diego, CA USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
- [10] Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab[J]. BLOOD, 2019, 133 (19) : 2031 - 2042Byrd, John C.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAHillmen, Peter论文数: 0 引用数: 0 h-index: 0机构: Leeds Teaching Hosp, St James Inst Oncol, Leeds, W Yorkshire, England Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAO'Brien, Susan论文数: 0 引用数: 0 h-index: 0机构: UC Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USABarrientos, Jacqueline C.论文数: 0 引用数: 0 h-index: 0机构: Zucker Sch Med Hofstra Northwell, Lake Success, NY USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAReddy, Nishitha M.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USACoutre, Steven论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Stanford, CA 94305 USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USATam, Constantine S.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia St Vincents Hosp, Melbourne, Vic, Australia Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAMulligan, Stephen P.论文数: 0 引用数: 0 h-index: 0机构: Royal North Shore Hosp, Sydney, NSW, Australia Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAJaeger, Ulrich论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Div Hematol & Hemostaseol, Vienna, Austria Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USABarr, Paul M.论文数: 0 引用数: 0 h-index: 0机构: Univ Rochester, Med Ctr, Rochester, NY 14642 USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAFurman, Richard R.论文数: 0 引用数: 0 h-index: 0机构: New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAKipps, Thomas J.论文数: 0 引用数: 0 h-index: 0机构: UCSD Moores Canc Ctr, San Diego, CA USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAThornton, Patrick论文数: 0 引用数: 0 h-index: 0机构: Beaumont Hosp, Dublin, Ireland Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAMoreno, Carol论文数: 0 引用数: 0 h-index: 0机构: Hosp Santa Creu St Pau, Barcelona, Spain Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAMontillo, Marco论文数: 0 引用数: 0 h-index: 0机构: Osped Niguarda Ca Granda, Milan, Italy Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAPagel, John M.论文数: 0 引用数: 0 h-index: 0机构: Swedish Canc Inst, Hematol Malignancies Program, Seattle, WA USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USABurger, Jan A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAWoyach, Jennifer A.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USADai, Sandra论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics LLC, Sunnyvale, CA USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAVezan, Remus论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics LLC, Sunnyvale, CA USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USAJames, Danelle F.论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics LLC, Sunnyvale, CA USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USABrown, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, CLL Ctr, Boston, MA 02115 USA Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA